Thank you for taking the time to visit Anelixis Pharmaceuticals website. Newly established in 2021, Anelixis is an innovative company, with a mission to support partners in maximizing the value and returns of their life science assets across the entire product portfolio continuum.
With a long-time expertise in the Greek market, added to extended exposure also to international healthcare environments, Anelixis can build scalable, customised solutions that are on demand for small to multinational organisations, while at the same time we are exploring patient-driven, cost-effective therapeutic options to launch in the territory.
At Anelixis, we are a diverse collective of experts who are passionate about what they do every single day. As a truly customer-centric company, we will be happy to meet and discuss with you how we can fulfil our mission to serve patients and their families in their fight against disease.
Yours sincerely,
Sotiris Botozis, BPHARM, IMBA
Managing Director
